Free Trial

Capricor Therapeutics (CAPR) Short Interest Ratio & Short Volume

Capricor Therapeutics logo
$6.79 -0.27 (-3.82%)
Closing price 07/28/2025 04:00 PM Eastern
Extended Trading
$7.00 +0.21 (+3.12%)
As of 08:52 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Capricor Therapeutics Short Interest Data

Capricor Therapeutics (CAPR) has a short interest of 11.17 million shares, representing 27.32% of the float (the number of shares available for trading by the public). This marks a 9.40% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.4, indicating that it would take 4.4 days of the average trading volume of 2.62 million shares to cover all short positions.

Current Short Interest
11,170,000 shares
Previous Short Interest
10,210,000 shares
Change Vs. Previous Month
+9.40%
Dollar Volume Sold Short
$110.92 million
Short Interest Ratio
4.4 Days to Cover
Last Record Date
June 30, 2025
Outstanding Shares
45,680,000 shares
Short Percent of Float
27.32%
Today's Trading Volume
1,923,409 shares
Average Trading Volume
2,620,708 shares
Today's Volume Vs. Average
73%
Short Selling Capricor Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Capricor Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CAPR Short Interest Over Time

CAPR Days to Cover Over Time

CAPR Percentage of Float Shorted Over Time

Capricor Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/202511,170,000 shares $110.92 million +9.4%27.3%4.4 $9.93
6/15/202510,210,000 shares $120.27 million -7.9%25.0%4 $11.78
5/31/202511,080,000 shares $110.80 million -19.6%27.7%5.3 $10.00
5/15/202513,780,000 shares $131.74 million +33.3%34.4%6.7 $9.56
4/30/202510,340,000 shares $131.32 million -3.1%N/A6.1 $12.70
4/15/202510,670,000 shares $104.78 million +14.7%26.7%8 $9.82
3/31/20259,300,000 shares $88.26 million +2.5%23.2%7.5 $9.49
3/15/20259,070,000 shares $120.00 million +11.0%22.7%7.6 $13.23
2/28/20258,170,000 shares $125.65 million +0.1%20.4%6.6 $15.38
2/15/20258,160,000 shares $130.15 million +6.4%20.4%6.9 $15.95
1/31/20257,670,000 shares $115.36 million +1.1%N/A6.5 $15.04
1/15/20257,590,000 shares $102.24 million -4.5%N/A6.1 $13.47
12/31/20247,950,000 shares $109.71 million +42.2%N/A4.8 $13.80
12/15/20245,590,000 shares $74.12 million +26.8%N/A1.6 $13.26
11/30/20244,410,000 shares $83.83 million +14.6%N/A1.3 $19.01
11/15/20243,850,000 shares $71.65 million -27.1%N/A1.2 $18.61
10/31/20245,280,000 shares $106.13 million -14.6%N/A1.8 $20.10
10/15/20246,180,000 shares $133.49 million +17.9%N/A2.1 $21.60
9/30/20245,240,000 shares $79.70 million -30.4%N/A2.1 $15.21
9/15/20247,530,000 shares $34.56 million +0.8%N/A8.5 $4.59
8/31/20247,470,000 shares $34.14 million +6.7%N/A19.5 $4.57
8/15/20247,000,000 shares $27.30 million +12.7%N/A16.5 $3.90
7/31/20246,210,000 shares $25.21 million +5.8%N/A14.4 $4.06
7/15/20245,870,000 shares $27.35 million +25.7%N/A13.6 $4.66
6/30/20244,670,000 shares $22.28 million +3.6%N/A10.8 $4.77
6/15/20244,510,000 shares $23.32 million -1.3%N/A12.6 $5.17
5/31/20244,570,000 shares $25.96 million +8.6%N/A12 $5.68
5/15/20244,210,000 shares $22.44 million +1.7%N/A11.6 $5.33
4/30/20244,140,000 shares $21.82 million +15.3%N/A12.8 $5.27
4/15/20243,590,000 shares $21.04 million +2.6%N/A12 $5.86
3/31/20243,500,000 shares $23.77 million +8.4%N/A13 $6.79
3/15/20243,230,000 shares $20.64 million +19.6%N/A11.8 $6.39
2/29/20242,700,000 shares $11.34 million +0.8%N/A10.3 $4.20
2/15/20242,680,000 shares $10.10 million -0.4%N/A11.5 $3.77
1/31/20242,690,000 shares $10.87 million No ChangeN/A11.2 $4.04
1/15/20242,690,000 shares $11.89 million +14.5%N/A11 $4.42
12/31/20232,350,000 shares $11.49 million +10.3%N/A9.6 $4.89
12/15/20232,130,000 shares $9.24 million +45.9%N/A7.2 $4.34
11/30/20231,460,000 shares $4.34 million +7.4%N/A5.8 $2.97
11/15/20231,360,000 shares $4.37 million +10.6%N/A5.4 $3.21
Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)

tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.

Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow
10/31/20231,230,000 shares $3.47 million +1.7%N/A4.7 $2.82
10/15/20231,210,000 shares $3.46 million +80.8%N/A5 $2.86
9/30/2023669,100 shares $2.29 million +22.2%N/A3.2 $3.42
9/15/2023547,600 shares $3.43 million +36.4%N/A4.4 $6.26
8/31/2023401,500 shares $2.60 million +27.3%N/A3.2 $6.48
8/15/2023315,500 shares $2.25 million +14.0%N/A3.1 $7.14
7/31/2023276,700 shares $1.22 million +0.8%N/A3.7 $4.40
7/15/2023274,500 shares $1.23 million -0.3%N/A4 $4.48
6/30/2023275,200 shares $1.32 million +6.5%N/A3.7 $4.78
6/15/2023258,400 shares $1.24 million +0.8%N/A3.5 $4.80
5/31/2023256,300 shares $1.16 million -13.1%N/A3.8 $4.53
5/15/2023294,800 shares $1.24 million +11.0%N/A4.1 $4.19
4/30/2023265,700 shares $1.03 million +0.5%N/A3.5 $3.89
4/15/2023264,500 shares $1.16 million -3.8%N/A2.9 $4.38
3/31/2023274,800 shares $1.16 million -22.3%N/A2.9 $4.22
3/15/2023353,500 shares $1.58 million +4.5%N/A3.5 $4.47
2/28/2023338,200 shares $1.54 million +8.7%N/A3.3 $4.55
2/15/2023311,100 shares $1.25 million -5.2%N/A2.9 $4.03
1/31/2023328,300 shares $1.39 million -4.3%N/A2.8 $4.22
1/15/2023343,100 shares $1.50 million +0.7%N/A2.8 $4.38
12/30/2022340,900 shares $1.32 million +9.4%N/A2.5 $3.86
12/15/2022311,700 shares $1.21 million +30.8%N/A1.9 $3.89
11/30/2022238,400 shares $1.07 million -8.5%N/A1.4 $4.47
11/15/2022260,600 shares $1.06 million +5.3%N/A1.4 $4.09
10/31/2022247,500 shares $1.38 million -16.9%N/A1.2 $5.56
10/15/2022297,800 shares $1.74 million -10.0%N/A1.5 $5.83
9/30/2022330,900 shares $1.99 million +55.3%N/A1.7 $6.00
9/15/2022213,100 shares $1.25 million -25.5%N/A1.2 $5.87
8/31/2022286,100 shares $1.67 million -5.9%N/A1.7 $5.82
8/15/2022304,100 shares $1.49 million -15.2%N/A2.2 $4.89
7/31/2022358,500 shares $1.65 million -9.1%N/A3.2 $4.61
7/15/2022394,500 shares $1.99 million -9.6%N/A3.4 $5.05
6/30/2022436,600 shares $1.52 million -12.5%N/A3.8 $3.49
6/15/2022499,100 shares $2.05 million -2.7%2.5%3.1 $4.11
5/31/2022512,800 shares $1.86 million -8.6%N/A3 $3.63
5/15/2022561,000 shares $1.72 million -4.4%N/A3 $3.06
4/30/2022586,600 shares $1.86 million -9.2%N/A2.9 $3.17
4/15/2022645,800 shares $2.12 million -7.1%N/A1.7 $3.29
3/31/2022695,100 shares $2.38 million -3.2%N/A1.8 $3.43
3/15/2022718,300 shares $2.97 million -20.7%N/A2.1 $4.14
2/28/2022905,200 shares $3.67 million +4.1%N/A2.6 $4.05
2/15/2022869,900 shares $3.76 million -7.0%N/A2.5 $4.32
1/31/2022934,900 shares $3.34 million +69.6%N/A2.6 $3.57
1/15/2022551,200 shares $1.70 million -18.3%N/A1.9 $3.09
12/31/2021675,000 shares $1.98 million -13.7%N/A3.5 $2.93
12/15/2021781,900 shares $2.47 million -12.1%N/A1.2 $3.16
11/30/2021889,000 shares $3.00 million -2.5%N/A1.3 $3.37
11/15/2021912,000 shares $3.12 million +0.4%N/A1.4 $3.42
10/29/2021908,600 shares $3.38 million -11.8%4.0%1.4 $3.72
10/15/20211,030,000 shares $4.08 million -12.0%4.6%1.6 $3.96
Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)

tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.

Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow
9/30/20211,170,000 shares $4.70 million +60.5%5.2%1.7 $4.02
9/15/2021728,900 shares $3.24 million +8.6%3.2%1.1 $4.45
8/31/2021671,100 shares $3.36 million -10.3%3.0%1.9 $5.01
8/13/2021748,100 shares $3.02 million -30.7%3.3%2.2 $4.04
7/30/20211,080,000 shares $4.72 million -49.8%4.8%3 $4.37
7/15/20212,150,000 shares $9.31 million -4.9%9.6%3.9 $4.33
6/30/20212,260,000 shares $11.59 million +17.7%10.1%4.1 $5.13
6/15/20211,920,000 shares $8.70 million +10.3%8.6%3.6 $4.53
5/28/20211,740,000 shares $6.59 million -0.6%7.8%4.1 $3.79
5/14/20211,750,000 shares $5.53 million +53.5%N/A3.7 $3.16
4/30/20211,140,000 shares $5.18 million +30.7%N/A2.1 $4.54
4/15/2021872,200 shares $3.55 million -7.2%N/A1.4 $4.07
3/31/2021939,500 shares $4.34 million +116.8%N/A1 $4.62
3/15/2021433,400 shares $2.25 million +25.6%N/A0.4 $5.18
2/26/2021345,200 shares $2.12 million -29.4%N/A0.4 $6.14
2/12/2021489,100 shares $3.81 million -29.3%N/A0.5 $7.80
1/29/2021691,900 shares $4.41 million -9.5%N/A0.7 $6.38
1/15/2021764,800 shares $3.70 million +0.9%N/A0.9 $4.84
12/31/2020758,000 shares $2.80 million -0.9%N/A1.2 $3.70
12/15/2020765,000 shares $3.27 million -29.8%N/A1.6 $4.27
11/30/20201,090,000 shares $4.68 million -12.1%N/A1.5 $4.29
11/15/20201,240,000 shares $5.39 million +4.2%N/A1.4 $4.35
10/30/20201,190,000 shares $4.95 million -9.9%N/A1.2 $4.16
10/15/20201,320,000 shares $6.40 million -8.3%N/A0.6 $4.85
9/30/20201,440,000 shares $7.56 million -1.4%N/A0.5 $5.25
9/15/20201,460,000 shares $6.83 million -24.0%N/A0.5 $4.68
8/31/20201,920,000 shares $11.58 million -6.8%N/A0.7 $6.03
8/14/20202,060,000 shares $12.75 million +73.1%N/A0.8 $6.19
7/31/20201,190,000 shares $9.47 million +166.9%N/A0.4 $7.96

CAPR Short Interest - Frequently Asked Questions

What is Capricor Therapeutics' current short interest?

Short interest is the volume of Capricor Therapeutics shares that have been sold short but have not yet been covered or closed out. As of June 30th, investors have sold 11,170,000 shares of CAPR short. 27.32% of Capricor Therapeutics' shares are currently sold short. Learn More on Capricor Therapeutics' current short interest.

What is a good short interest ratio for Capricor Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CAPR shares currently have a short interest ratio of 4.0. Learn More on Capricor Therapeutics's short interest ratio.

Which institutional investors are shorting Capricor Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Capricor Therapeutics: Jane Street Group LLC, Caption Management LLC, HAP Trading LLC, Torno Capital LLC, Persistent Asset Partners Ltd, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Capricor Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 27.32% of Capricor Therapeutics' floating shares are currently sold short.

Is Capricor Therapeutics' short interest increasing or decreasing?

Capricor Therapeutics saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 11,170,000 shares, an increase of 9.4% from the previous total of 10,210,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Capricor Therapeutics' short interest compare to its competitors?

27.32% of Capricor Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Capricor Therapeutics: Intellia Therapeutics, Inc. (30.02%), WAVE Life Sciences Ltd. (73.25%), Pharvaris N.V. (4.50%), CureVac N.V. (0.93%), Cidara Therapeutics, Inc. (12.30%), Phibro Animal Health Corporation (4.68%), Aurinia Pharmaceuticals Inc (8.39%), Enliven Therapeutics, Inc. (15.81%), Structure Therapeutics Inc. Sponsored ADR (13.40%), Praxis Precision Medicines, Inc. (9.77%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks.

What does it mean to sell short Capricor Therapeutics stock?

Short selling CAPR is an investing strategy that aims to generate trading profit from Capricor Therapeutics as its price is falling. CAPR shares are trading down $0.27 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Capricor Therapeutics?

A short squeeze for Capricor Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CAPR, which in turn drives the price of the stock up even further.

How often is Capricor Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CAPR, twice per month. The most recent reporting period available is June, 30 2025.




This page (NASDAQ:CAPR) was last updated on 7/29/2025 by MarketBeat.com Staff
From Our Partners